Back to search

Cornell University

Developing Oligothioetheramides as Alternatives to Traditional Antibiotics

Abstract

dc:description.abstract

Antibiotic resistance poses a serious threat to global health as new antibiotic development lags behind the emergence of increasingly resistant bacteria. Antimicrobial peptides offer a promising source of new antibiotics, but have not achieved broad clinical success due to factors including systemic host toxicity and susceptibility to proteolytic degradation. Oligothioetheramides (oligoTEAs) are synthetic, sequence-defined peptidomimetics designed to retain the positive traits of antimicrobial peptides with enhanced proteolytic stability. By investigating the impacts of physicochemical properties including cationic type, charge density, and backbone hydrophobicity, we demonstrate the importance of guanidinium functionalization and carefully tuned backbone hydrophobicity to achieve potent antibacterial activity with minimal mammalian cell toxicity. This knowledge was used to synthesize oligoTEAs with activities that rival clinical antibiotics. However, similar to polycationic macromolecules, oligoTEAs are toxic upon intravenous injection in vivo. We seek to mitigate this toxicity by conjugating oligoTEAs to non-toxic moieties which can shield the cationic charge. As this lowers both toxicity and activity, the conjugates contain a peptide linker which cleaves in the body to reactivate the antimicrobial agent. By controlling the linker cleavage kinetics, we seek to optimize oligoTEA reactivation for potent activity and suppression of systemic toxicity. Building upon these results, we begin investigations into antibody-oligoTEA conjugates for improved selectivity and targeting. Altogether, this body of work illustrates the potential of oligoTEAs and oligoTEA conjugates to develop therapeutics that aid in the fight against antibiotic resistance.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Chemical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Chemical Engineering
Grantor
Cornell University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Artim, Christine Mary
Chair dc:contributor.chair
  • Alabi, Christopher A
Committee members dc:contributor.committeemember
  • Ober, Christopher K.
  • DeLisa, Matthew
  • Daniel, Susan

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
13254325
Dc Identifier Other
ProQuest Submission ID: 12010
ProQuest Publication ID: 27993220

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Artim, Christine Mary. Developing Oligothioetheramides as Alternatives to Traditional Antibiotics. Doctor of Philosophy thesis, Cornell University, 2020. https://hdl.handle.net/1813/70358